G12S (p.Gly12Ser) variant of KRAS (GTPase KRas)
G12S (p.Gly12Ser) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of KRAS-related disorder; Vascular malformation; Cardiofaciocutaneous syndrome 2. The available variant effect predictions contribute to a CATVariant prioritization score of 0.72 / 1. The record also includes population frequency data, published literature, and structural context.
G12S (p.Gly12Ser) variant details
- p.Gly12Ser
- rs121913530
- ClinGen CA135565
- NCI-TCGA Cosmic COSV5549
- cosmic curated COSV55497
- Pathogenic
- KRAS-related disorder; Vascular malformation; Cardiofaciocutaneous syndrome 2
- Missense
- Variant Prioritization Score for Impact Estimate 0.72
- REVEL 0.79
- ESM-1b 1.00
- AlphaMissense 0.98
- MetaLR 0.43
- MetaSVM -0.15
- CADD 28.30
- ClinVar: Pathogenic (KRAS-related disorder; Vascular malformation; Cardiofaciocutaneo)
- EBI: Pathogenic (in GASC and JMML)
- UniProt: Pathogenic (in GASC and JMML)
- Most common in the Non-Finnish European population (allele frequency 4.5e-06)
- Structural context available
- Cited in: Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with… (PMID 16533793)
- Cited in: The consensus coding sequences of human breast and colorectal cancers. (PMID 16959974)